about
Prostate cancer: 13. Whose prostate is it anyway? The view from the other side of the examining tableTR4 nuclear receptor functions as a tumor suppressor for prostate tumorigenesis via modulation of DNA damage/repair systemUnderstanding obesityHigh expression of DDX20 enhances the proliferation and metastatic potential of prostate cancer cells through the NF-κB pathway.miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer.Tumor-suppressive microRNA-145 induces growth arrest by targeting SENP1 in human prostate cancer cells.Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysisAssociations of serum vitamin A and carotenoid levels with markers of prostate cancer detection among US menUtilization of prostate cancer screening according to dietary patterns and other demographic variables. The adventist health study-2.The burden of prostate cancer in Canada.Clinical nutrition: a new series.Elevated Jagged-1 and Notch-1 expression in high grade and metastatic prostate cancers.Prostate cancer from a patient's perspective.The influence of occupational exposure to pesticides, polycyclic aromatic hydrocarbons, diesel exhaust, metal dust, metal fumes, and mineral oil on prostate cancer: a prospective cohort study.Prostate cancer. What men want from their family physicians.The more the better?PSA screening: a view from the front lines. North York General-Branson Practice-Based Small Group.Understanding obesity.
P2860
Q33585795-483DE017-3C0D-4B78-84D7-259E4F1C2E1EQ33705275-EB6B7BF5-0DB5-4765-BCE9-ABEB5AD36C86Q34031820-A1E16094-6145-4CFD-B6A7-699C817299C6Q34523912-77B5D5C3-D30D-4E86-AF70-1E85C41B65CBQ35195342-99FD8379-6BC5-4C9E-9CD5-98F993113666Q35538436-F1E49AFA-3415-4A97-9AAF-D56813A4465AQ36110788-09652108-DEF2-4C47-BB29-5F60A3E31DA3Q36237495-2927374F-C1D8-4D99-8089-6C1ED84EB92EQ36983384-AC799425-4715-486D-8C1D-9C2BC78222C8Q37233474-5EB71B2D-20BC-4DFA-8ACA-C0F185ADE2B8Q39434339-C686AC30-CCB4-41BE-880A-12CA19512F4FQ40029207-46C74EFA-FE54-44A4-89DE-7C44267D3E62Q42225185-E15D7490-074C-4AC9-8690-B85AC8B0D98CQ42245001-1F87AE96-C273-4DB3-885A-138C714E9987Q42848425-D3DBD1BF-4A60-494C-9115-06E73A491056Q43012551-5BE112BF-F6D1-409C-99AC-434DB639BDBFQ43013882-0A8FE0B1-CDE2-4C38-9CB3-CB5D4FB3BA37Q55419068-220BED73-ECAA-4654-A25B-4C310E2B551D
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Prostate cancer: 3. Individual risk factors
@ast
Prostate cancer: 3. Individual risk factors
@en
Prostate cancer: 3. Individual risk factors
@en-gb
Prostate cancer: 3. Individual risk factors
@nl
type
label
Prostate cancer: 3. Individual risk factors
@ast
Prostate cancer: 3. Individual risk factors
@en
Prostate cancer: 3. Individual risk factors
@en-gb
Prostate cancer: 3. Individual risk factors
@nl
prefLabel
Prostate cancer: 3. Individual risk factors
@ast
Prostate cancer: 3. Individual risk factors
@en
Prostate cancer: 3. Individual risk factors
@en-gb
Prostate cancer: 3. Individual risk factors
@nl
P2860
P3181
P1476
Prostate cancer: 3. Individual risk factors
@en
P2093
Fleshner N
Gallagher RP
P2860
P304
P3181
P407
P577
1998-10-01T00:00:00Z